Navigation Links
ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
Date:1/23/2008

- First phase of development of product to reduce risk of variant

Creutzfeldt-Jakob Disease from plasma product completed on schedule

- Scale-up phase worth $ 1 M to ProMetic - Multi-million dollar long-term agreement to supply prion removal affinity

resin following regulatory approval anticipated by mid-2008

MONTREAL and CAMBRIDGE, United Kingdom, Jan. 23 /PRNewswire-FirstCall/ - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") announces that its UK-based subsidiary, ProMetic BioSciences Ltd ("PBL"), has successfully completed the first phases of development utilizing Pathogen Removal and Diagnostic Technologies Inc.'s ("PRDT") ligand technology for prion binding and removal from a plasma product for biopharmaceutical use marketed by a major European plasma fractionator. The program, which is progressing on schedule with expected completion of the scale-up phase in June 2008, is worth approximately $ 1 M to ProMetic. This will be followed by a multi-million dollar long-term supply agreement for the prion reduction resin. The supply agreement is in final stage of negotiation and commercial quantities of resin supply could commence as soon as mid-2008, assuming regulatory approval of the product.

The incorporation in this new application of PRDT's proprietary ligand technology, which is licensed exclusively to PBL, ensures the removal of any abnormal prion proteins that may be present in donated plasma. This additional process will add another level of safety to the already established treatment protocols and is particularly relevant since there is no commercially available diagnostic test for detection of the blood-borne form of the variant Creutzfeldt-Jakob disease ("vCJD") agent.

"We have now demonstrated that the use of the prion reduction technology in process applications is practical," stated Dr. Peter Edwardson, Vice-President, Medical Technologies of ProMetic. "We have already commenced scale
'/>"/>

SOURCE PROMETIC LIFE SCIENCES INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
2. Vapotherm(R) Announces Validation of U.S. Patent
3. Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders
4. Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II
5. Elekta Announces First Two Clinical Sites Using VMAT Cancer Treatment Capability
6. Amarin Provides Business Update and Announces Implementation of Reverse Stock Split
7. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
8. Peptimmune Announces First Close of Series D Private Financing
9. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
10. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
11. Vasogen Announces 2007 Year-End Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...rk investment bank KTA Capital,s client Neuren Pha...l convertible note private placement with a U.S. i...rranged by KTA Capital as Neuren,s exclusive place... New York (PRWEB) November 23, 2009 -- The indepen...uot;KTA Capital") has announced that its clie...
(Date:11/24/2009)...re employment grew by 29,000 jobs in October, and... growth during the U.S. recession. However, clinic...ealth systems are coming closer to having to actua...trators. , (Vocus) Novemb...owing in October despite the shedding of jobs in m...
(Date:11/24/2009)...wire/ -- Blue Marble Energy Corp. announced today ... Authority (OPDA) were recently awarded $2 million...zation Board (CERB) in a private/public partnershi...ical biorefinery in Lincoln County, WA. ,, "T...pment of our biorefinery and bring over 70 green j...
(Date:11/24/2009)...2009 Arena Pharmaceutica...he company is scheduled to present at the Piper Ja...er 1, 2009 at 11:30 a.m. Eastern Time (8:30 a.m. P...ork City. Jack Lief, Arena,s President and Chief E...iew of the company, including its clinical develop...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
...ry 27 Debiopharm Group,(Debiopharm), a global ind...focusing on serious medical conditions and particu...of a Debiopharm oncology chair at the Ecole,Polyte...ignal Transduction,in Oncogenesis. Funded through ...chair is to leverage the wide scope of ideas and i...
...rchase Agreement Entered Into Between Genmab, an...DL,s Manufacturing Facility has Rece... Genmab A/S (OMX: GEN),announced today that the p...PDL BioPharma, Inc. under which Genmab would acqui...ved antitrust clearance from the US,antitrust auth...
...es Leading Mobile Computing Workstations with Un... with Patients, COLUMBUS, Ohio, Feb. 26 Artromic...d healthcare technology solutions for the,long-ter...sive referral,agreement with McKesson Automation, ...healthcare services, automation and information te...
Other Biology Technology:Debiopharm and EPFL Establish an Oncology Chair 2Purchase Agreement for Antibody Manufacturing Facility Receives Antitrust Clearance 2Artromick Aligns with McKesson to Enhance Medication Safety at the Patient's Bedside 2Artromick Aligns with McKesson to Enhance Medication Safety at the Patient's Bedside 3
(Date:11/26/2009)...are the bare essentials of life, the indispensable...urvive on its own? Can we describe the molecular a...anism functions as a system? These are just some o...etween the European Molecular Biology Laboratory (...gulacio Genmica (CRG) in Barcelona, Spain, set out...
(Date:11/25/2009)...fficers and ambulance workers faced a terrifying r...ey battled to save people from the collapsing Twin... evacuated as many people as they could in an area...aking their jobs even harder was the problem of po...latives jammed mobile networks with calls and the ...
(Date:11/25/2009)...as vital to your health as what you eat, found res...ies. Their experiments in mice revealed that the d...e liverthe body,s metabolic clearinghouseis mostly...ircadian clock as conventional wisdom had it. , ...ge number of genes completely independent of the c...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3CryoLife to Present at Upcoming Investor Conferences in New York 6166 1CryoLife to Present at Upcoming Investor Conferences in New York 6166 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 6161 1Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 6161 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 6161 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 6161 4Aware Inc Announces Support for New ITU Testing Standard with Line Diagnostics Platform 10688 1Aware Inc Announces Support for New ITU Testing Standard with Line Diagnostics Platform 10688 2Aware Inc Announces Support for New ITU Testing Standard with Line Diagnostics Platform 10688 3Aware Inc Announces Support for New ITU Testing Standard with Line Diagnostics Platform 10688 4
...choanoflagellates have in common? More than you,d ...me shows these ancient organisms have similar leve...s, including humans, use to communicate with each ... in the Proceedings of the National Academies of ...llates, role as an evolutionary link between singl...
...rkinson,s Disease Foundation (PDF) is pleased to a...ternational Research Grants and Fellowship Program...f 19 Parkinson,s scientists, chosen on April 11 fr...c review committee led by Stanley Fahn, M.D., PDF,... awardees, who hail from around the world, include...
...evokes memories of promising spring days and visio...been well-loved staples in America,s yards and gar...ry. , Native to East Asia and Southeast Europe, l...ettlers and were sold in American nurseries as ear...ica may be those at the Governor Wentworth estate ...
Other Biology News:Crossed (evolutionary) signals? 2Crossed (evolutionary) signals? 3The Parkinson's Disease Foundation awards $950,000 in seed grants 2The Parkinson's Disease Foundation awards $950,000 in seed grants 3Patriotic new lilacs introduced 2
...uses a simplified procedure and streamlines the bi...it is based on the three step reaction that takes ...cytosine is converted into uracil. The EZ DNA Meth...eaction eliminates several precipitation steps and...
...ys are intended for laboratory research use only. ...ered formalin and embedded in paraffin. Tissue id...ied pathologists. Tissue cores were removed from ...ipient paraffin block, in an array pattern, using ...
...ys are intended for laboratory research use only. ...ered formalin and embedded in paraffin. Tissue id...ied pathologists. Tissue cores were removed from ...ipient paraffin block, in an array pattern, using ...
...issue extracts (liver, kidney, spleen, and heart) ...so tested with microsomal fractions prepared from ...and reliable method for measuring NDPase activity ...f the inorganic phosphate released from NDP by the...
Biology Products: